{
    "nctId": "NCT00247663",
    "briefTitle": "Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer",
    "officialTitle": "Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Postmenopausal Women With Advanced Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 17,
    "primaryOutcomeMeasure": "Safety during treatment",
    "eligibilityCriteria": "Inclusion Criteria:\n\n- Patients which participated in double blind study\n\nExclusion Criteria:\n\n* Patients with intolerable toxicity.\n* Patients which confirmed progressive disease during double blind study.\n* Patients which have received concurrent anti-cancer therapy during double blind study.",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}